Hydroxychloroquine, an autophagy inhibitor, or the deletion of autophagy-related genes ATG13 and ATG14 can prevent the breakdown of MHC-I protein and enhance the presence of CD8+ T cells in tumor areas, leading to an immune response against tumors. This evidence concerns the gene CD8A and neoplasm.